A novel treatment regimen for poor-prognosis or relapsed germ-cell tumors

被引：0
|
作者：
机构：
来源：
Nature Clinical Practice Oncology | 2007年 / 4卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：620 / 621
页数：1
相关论文
共 50 条
  • [31] TREATMENT OF MALIGNANT GERM-CELL TUMORS
    DAUGAARD, G
    HANSEN, HH
    RORTH, M
    ANNALS OF ONCOLOGY, 1990, 1 (03) : 195 - 202
  • [32] A phase III trial of personalized chemotherapy based on serum tumor marker decline in poor-prognosis germ-cell tumors: Results of GETUG 13.
    Fizazi, Karim
    Pagliaro, Lance C.
    Flechon, Aude
    Mardiak, Jozef
    Geoffrois, Lionnel
    Kerbrat, Pierre
    Chevreau, Christine
    Delva, Remy
    Rolland, Frederic
    Theodore, Christine
    Roubaud, Guilhem
    Gravis, Gwenaelle
    Eymard, Jean-Christophe
    Malhaire, Jean-pierre
    Linassier, Claude
    Habibian, Muriel
    Journeau, Florence
    Logothetis, Christopher
    Culine, Stephane
    Laplanche, Agnes
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (18)
  • [33] A phase III trial of personalized chemotherapy based on serum tumor marker decline in poor-prognosis germ-cell tumors: Results of GETUG 13.
    Fizazi, Karim
    Pagliaro, Lance C.
    Flechon, Aude
    Mardiak, Jozef
    Geoffrois, Lionnel
    Kerbrat, Pierre
    Chevreau, Christine
    Delva, Remy
    Rolland, Frederic
    Theodore, Christine
    Roubaud, Guilhem
    Gravis, Gwenaelle
    Eymard, Jean-Christophe
    Malhaire, Jean-pierre
    Linassier, Claude
    Habiban, Muriel
    Journeau, Florence
    Logothetis, Christopher
    Culine, Stephane
    Laplanche, Agnes
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [34] Assessment of bleomycin pulmonary toxicity in men with poor-prognosis non-seminomatous germ-cell tumors treated in the GETUG 13 phase III trial
    Naoun, N.
    Le Teuff, G.
    Pagliaro, L.
    Flechon, A.
    Mardiak, J.
    Geoffrois, L.
    Kerbrat, P.
    Chevreau, C. M.
    Delva, R.
    Rolland, F.
    Theodore, C.
    Roubaud, G.
    Gravis, G.
    Eymard, J-C.
    Malhaire, J. P.
    Linassier, C.
    Reckova, M.
    Nenan, S.
    Culine, S.
    Fizazi, K.
    ANNALS OF ONCOLOGY, 2021, 32 : S719 - S719
  • [35] Personalized Chemotherapy on the Basis of Tumor Marker Decline in Poor-Prognosis Germ-Cell Tumors: Updated Analysis of the GETUG-13 Phase III Trial
    Fizazi, Karim
    Le Teuff, Gwenael
    Flechon, Aude
    Pagliaro, Lance
    Mardiak, Josef
    Geoffrois, Lionnel
    Laguerre, Brigitte
    Chevreau, Christine
    Delva, Remy
    Rolland, Frederic
    Theodore, Christine
    Roubaud, Guilhem
    Gravis, Gwenaelle
    Eymard, Jean-Christophe
    Cancel, Mathilde
    Juzyna, Beata
    Reckova, Maria
    Naoun, Natacha
    Logothetis, Christopher
    Culine, Stephane
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (28)
  • [36] GERM-CELL TUMORS
    STANHOPE, CR
    SMITH, JP
    CLINICS IN OBSTETRICS AND GYNAECOLOGY, 1983, 10 (02): : 357 - 364
  • [37] Germ-cell tumors
    Shamash, Jonathan
    Stebbing, Justin
    Powles, Thomas
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (17): : 1771 - 1772
  • [38] GERM-CELL TUMORS
    SCHWARTZ, MK
    TUMOR BIOLOGY, 1987, 8 (2-3) : 106 - 108
  • [39] GERM-CELL TUMORS
    WILLIAMS, SD
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1992, 6 (04) : 967 - 974
  • [40] THE INVESTIGATION AND TREATMENT OF GERM-CELL TUMORS OF THE TESTIS
    SLATER, AJ
    JAMES, KW
    FIFIELD, R
    GROOM, GV
    CLINICAL RADIOLOGY, 1981, 32 (01) : 25 - 30
12345